“An innovative solution to
get healthy and manage your arthritis”
About MyArthritisRx
MyArthritisRx is a multidisciplinary self-management program that helps you manage your degenerative arthritis. The program empowers you to maximize non-surgical treatment and in some cases, postpone invasive and expensive surgery.
About our founding Team
Over 100 years of combined
Over 1000 publications on Arthritis
Over 30,000 patients seen combined
Understanding this paradigm shift, the mission of MyArthritisRx is to establish an innovative, evidence-based arthritis self-management program with the goal of empowering patient self-education and awareness, reducing healthcare resource utilization, avoiding unnecessary treatments, and improving clinical outcomes and patient satisfaction.
Our founding team has over 30 years of experience in arthritis care and research at academic medical centers across the country. Our digital platform lets patients self-evaluate their stage of degenerative arthritis and access a personalized care pathway. This allows patients to manage their condition while avoiding unnecessary treatments, reducing their out-of-pocket costs and increasing patient satisfaction.
Raj Karia is a Research Assistant Professor at New York University Langone Medical Center Orthopedic Hospital and the Director of the Center for Clinical Research in the Department of Orthopaedic Surgery. His research interests include patient engagement and the use of technology for population health. He is a graduate of Dartmouth College and received his Masters in Public Health from Dartmouth Medical School. He has published over 30 peer-reviewed scientific articles and received federal funding to support his research interests.
Raj Karia
Founder/CEO
Richard Iorio is the William and Susan Jaffe Professor of Orthopaedic Surgery at New York University Langone Medical Center Orthopedic Hospital and Chief of Adult Reconstruction at NYU Langone HJD. He co-founded Labrador Healthcare Consulting Services, Responsive Risk Solutions, and the Value Based Healthcare Consortium in 2015. He is a graduate of Harvard University and Boston University School of Medicine and practiced at Lahey Clinic for 21 years, before coming to New York in 2012. Dr. Iorio has published over 160 papers, 23 Book Chapters and participated in 25 funded grants. He was awarded the Lahey Clinic Research Award in 2008, the AAHKS Clinical Research Award in 2013, the Otto Aufranc Award from the Hip Society in 2014, The Kilfoyle Award from NEOS in 2000 and 2015, the Stinchfield Award from the Hip Society in 2016 and several AAOS Research Awards.
Richard Iorio
Founder/CMO
Thomas A. Einhorn, M.D. is Professor of Orthopaedic Surgery at New York University and Director of Clinical and Translational Research Development at New York University Langone Medical Center Orthopedic Hospital NYU Hospital for Joint Diseases. A graduate of Rutgers University and Cornell Medical College, he completed his internship at the Hospital of the University of Pennsylvania, orthopaedic residency at St. Luke’s Roosevelt Hospital, and a fellowship at the Hospital for Special Surgery. His professional interests include research into the role of stem cells in orthopaedic surgery, the repair and regeneration of bone and cartilage, reconstructive surgery of the hip and knee, and the treatment of metabolic bone diseases. He has served as Chairman of the Department of Orthopaedic Surgery at Boston University School of Medicine, Chairman of the Orthopaedics and Musculoskeletal Study Section of the National Institutes of Health, President of the Orthopaedic Research Society, President of the International Society for Fracture Repair, Vice Chair for Grants of the Orthopaedic Research and Education Foundation (OREF), and Chairman of both the Committee on Examinations and the Council on Research and Scientific Affairs of the American Academy of Orthopaedic Surgeons. His awards include the Marshall R. Urist Award and the Alfred R. Shands, Jr. Award from the Orthopaedic Research Society (ORS), the Distinguished Investigator Award from the ORS/OREF, the Kappa Delta Award from the American Academy of Orthopaedic Surgeons, the Dr. Marian Ropes Physician Achievement Award from the Arthritis Foundation and the Marshall Schiff Award from the American College of Rheumatology. He is currently the Editor of JBJS Reviews. An author of over 240 peer-reviewed articles, his career goals are dedicated to exploring the role of regenerative medicine in orthopaedic surgery.
Thomas Einhorn
Founder/Chief Scientific Officer
Dr. Band is the Chief Executive Officer of CytoDel LLC, an early stage biopharmaceutical company spun out of technology he co-developed at NYU. CytoDel has engineered recombinant derivatives of botulinum neurotoxin (BoNT) to create therapeutic fusion proteins, designed to deliver single chain antibodies to the inside of neurons. CytoDel’s lead product, Cyto-111, is the first drug ever to reverse symptoms of botulism in animals. Dr. Band also remains as Research Professor of Orthopaedic Surgery, Biochemistry, and Molecular Pharmacology in the NYU School of Medicine. He is a widely acknowledged as an expert on osteoarthritis, the extracellular matrix, hyaluronan, synovial fluid and intra-articular injection therapies. He spent eighteen years managing research and development at Biomatrix, an NYSE biotechnology company now owned by Sanofi. He founded and directed the Clinical Research Center at the New York University Orthopedic Hospital, and was a co-founder of the Joint Preservation and Arthritis Center. He is an author of approximately 70 peer-reviewed publications, numerous book chapters, and an inventor on 14 issued US patents and multiple foreign patents.
Philip Band
Founder/Chief Research Officer
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.
Manish Maheshwary
Founder/CIO
Dr. Zhou is the Data Group Lead in the Clinical Genomics Informatics at Icahn School of Medicine at Mount Sinai. He is in charge of managing and exploring large patient data, including NGS (next generation sequence) and EHR (electronic health record) data from Mount Sinai hospital. Prior to join Mount Sinai, Dr. Zhou was the Clinical Information Technology Director in the Department of Orthopaedic Surgery at New York Langone Medical Center. He built the patient reported outcome (PRO) system for the hospital which is still used daily by physicians and patients from multiple departments as part of standard of care. Dr. Zhou received his PhD degree from Columbia University on biomedical informatics and computational biology. He is experienced in building complicated healthcare IT platforms, data mining and developing predictive models from large data.
Sean Zhou
Chief of Data Scientist
Through our OA care and research, we provide a digital service for the self-management of arthritis.
Join our team to deliver personalized care to OA patients specific to their needs.
